semaglutide vs tirzepatide for diabetes vs. Weight Loss Semaglutide vs. Tirzepatide for weight

Assessment of Effect on CVS A total of 3,297 patients with T2D and high risk of CVD were randomised in 104-week double-blind trial to receive either semaglutide 0.5 mg/1 mg once weekly or placebo 0.5 mg/1 mg as an add-on to the conventional therapy of CVD for the next two years

Here is what you need to know

Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse

Ott C, Raff U, Schmidt S, et al

I have been exercising on my treadmill almost every day since I began taking GLP-1, and I started eating fruit twice a day because I keep hearing rumors that its a good idea

Prevalence and clinical profile of vitiligo in China: a community-based study in six cities